Prevention & care

Trichomoniasis: a protozoan STI, silent infection, test methods, treatment comparisons, and reinfection

6 sources · Latest source check 2026-10-13 UTC

On this page

Trichomoniasis, often shortened to trich, is a sexually transmitted infection caused by the protozoan parasite Trichomonas vaginalis. It usually affects the urogenital tract. It is different from bacterial vaginosis, genital herpes and a yeast infection, despite overlapping symptoms. Many infected people have no noticeable symptoms.[1][2]

Different tests detect different evidence

Different tests detect different evidence
Method	What it looks for
Wet-mount microscopy	Visible organisms in a prepared sample; sensitivity is limited.[3]
NAAT	Parasite genetic material, using an appropriate specimen and assay.[1]
Test of cure / later retesting	Treatment success and later reinfection are separate follow-up purposes.[3]

Discharge appearance does not establish one cause

Possible findings include vaginal discharge, irritation, pain with urination or sex, or urethral symptoms. These overlap with other infections and noninfectious conditions. CDC describes transmission during sexual contact even when symptoms are absent. A partner’s symptom-free status therefore does not exclude infection.[2]

Microscopy and molecular detection have different limits

WHO describes clinical assessment with microscopy, antigen or molecular testing. The sample and method must match the test’s validated use. CDC describes NAATs as more sensitive than a wet mount; a negative microscopy result can require further testing. Test availability varies, and one symptom or sample cannot identify every STI.[1][3]

Curable does not mean self-selected treatment is adequate

NHS describes antimicrobial treatment through sexual-health services and testing for relevant other infections. A medicine sold for yeast symptoms is not automatically effective against this parasite. Pregnancy, other medicines and recurrent infection change the assessment; the treatment plan needs the actual diagnosis and current local guidance.[4]

Treating one person may leave the exposure pathway active

NHS explains that current and recent sexual partners need appropriate care, with confidential notification support. Clinicians advise when sexual contact can resume. Completing one person’s treatment is different from preventing a new exposure, and condom use and partner care serve complementary purposes.[4]

Early residual material and later reinfection should not be conflated

CDC’s 2021 framework cautions against NAAT within three weeks after treatment completion when investigating recurrence, because residual nucleic acid may remain. It separately describes later retesting for women. These are different purposes; the clinical timeline and current local guidance matter when interpreting a repeat result.[3]

An association is not a guaranteed individual outcome

WHO associates infection with adverse birth outcomes and increased HIV acquisition risk. Those population associations are not a prediction for every individual or proof that every screening program improves all outcomes. Symptoms, pregnancy or exposure concerns need clinical assessment rather than an assumed yeast infection or a hygiene judgment.[1]

A suspected STI can be addressed without stigma

NHS describes private sexual-health care, appropriate samples and partner-support options. Douching or an unverified cleansing product is not a substitute for diagnosis and treatment. This page does not identify the cause of an individual discharge or supply a medication schedule.[4]

Susceptibility testing is a specialist tool with interpretation limits

CDC tests isolates from infections refractory to treatment and reports the concentration that stops parasite movement in culture. It states that established breakpoints for metronidazole and tinidazole are absent, although distributions can help interpretation. A laboratory susceptibility result therefore contributes to specialist management; it is not a universal numeric cutoff a reader can use to select treatment independently.[6]

Evidence & uncertainty

Antimicrobial treatment can cure infection; reinfection remains possible. Method and timing matter: a wet mount can miss infection, while molecular testing soon after treatment may detect residual material. A trial favoring one course in women does not establish the same choice for every population.[3][5]

Selected-source overview · Independent review pending

Published questions

Is trichomoniasis the same organism as a yeast infection?

Selected-source overview · Independent review pending. Read the evidence context.

Trichomonas vaginalis is a protozoan parasite, not a yeast.[1]

Evidence behind this answer

Trichomoniasis
agency condition or prevention explanation · 2025
Selected relevant original official page passages inspected · Protozoan cause, molecular testing and pregnancy/HIV associations